03 2020

Workshop "Heart Rate Variability - Clinical Applications" Kasprowisko 2020

Already today we invite users of Kasprowisko in Zakopane - one of the main cardiological conferences in Poland at the lecture by ExeMed: "Heart rate variability - clinical applications". The lecture will be conducted by dr Jakub Zieliński (Friday, March 6 between 11-12:30). During the occurrence of these most important parameters describing heart rate variability (HRV). The presented clinical applications of HRV and the possibility of a simple application for the so-called segregation of patients (triage) in hospital emergency departments (SOR) and a more accurate assessment of the patient's situation during ambulance transport.


02 2020

New functionality for the PulseGrid II Cardiomonitoring System!

For facilities where there is no available cardiologist, we have added another functionality to the system, making our product even more comfortable and accessible to everyone. From now on, descriptions of Holter examinations will be made for you remotely by a doctor cooperating with ExeMed! All you have to do is take advantage of our Pay Per Use offer with a description of the Holter study and it's ready! We work with cardiologists from all over Poland, dealing with the diagnosis and treatment of cardiological patients daily. Contact us and learn more about the Pay Per Use service.


12 2019

Happy New Year 2020!

We send heartfelt wishes from the whole ExeMed team for 2020. Thank you to our customers for the trust they have entrusted, thanks to you 2019 turned out to be very successful :) We are glad that there are more and more of us! See you in 2020!


12 2019

New medical facilities within ExeMed coverage!

Next medical institutions are replacing traditional solutions with modern medical technology. Only for the last week 5 clinics and 1 hospital joined us.
Thanks to this, the group of more accurately diagnosed patients is gowing. This will allow for a faster application of appropriate treatment.

More clinics and hospitals are expected to join us soon :) 


11 2019


The PulseGrid II Oxy Cardiomonitoring System is a new product in the ExeMed product line for monitoring patients' vital functions. The new product differs from the PulseGrid II which is already on the market THE pulse oximeter function measures arterial oxygen saturation. Like the other products in this line, PulseGrid II Oxy is also designed for remote and stationary cardiological monitoring. Thanks to this, medical facilities now can monitor dozens of patients at the same time on a multifaceted basis! PulseGrid II Oxy has been entirely developed and manufactured at ExeMed. The product, after obtaining the necessary certificates, has been approved for sale and is now available to customers in the European Union. 


11 2019


We have provided a set of new functionalities that significantly speed up work of cardiologists on
Holter applications.
These include, among others
✔️Automatic detection of noisy signal (we are the only one on the market with this functionality)
✔️Ventricular beats morphology s
✔️Speak plans with the ability to simultaneously mark multiple beats as templates
Thus, the application will become even easier to use!



10 2019


An intensive week is behind us! We had the pleasure to participate in the “29th International Public Health 2019 in Kyiv”. We found ourselves in a group of as many as 296 exhibitors from 16 countries. Importantly, we presented our PulseGrid II solution to specialists in the field of medicine, decision-makers from various regions of Ukraine representing both private and public medicine. We also met with our potential clients and partners, we tried to give everyone the most comprehensive answers about our product, and for those willing, we prepared a TelePulse II cardiomonitor (certified in Ukraine) with the possibility of testing at the fair. Our presence at the fair has enriched us with new experiences, contributing to the further development and sale of our products on foreign markets.


09 2019


What are the available ECGs for the heart?

An ECG of the heart can be carried out during normal patient activity, in a hospital or on an
outpatient basis. Continuous hospital testing is usually called ECG monitoring. During the
examination, the patient almost always stays in a room with increased supervision (ICU, cardiological hand, postoperative ward [POP]), and the ECG device is permanently mounted next to his bed.
Usually, in addition to the electrical activity of the heart, other physiological parameters are also monitored, and the monitoring device is most often called a cardiomonitor.

A patient who is in a better general condition can also be in an ordinary room in the ward, and the monitoring device is a small camera that the patient carries with him. The ECG signal is transmitted via radio waves (most often WiFi). Thus, the patient retains the ability to use the toilet himself, eat meals and as normal activity.
Holter examination is commonly used in outpatient care. During the examination, the patient carries a small ECG device. The recorded signal is recorded on a digital medium. After the examination, the record is analyzed by a cardiologist.
It is worth remembering, however, that the worlds of telemetry and Holter can permeate. In
particular, the signal from telemonitoring can be recorded and subjected to subsequent analysis. PulseGrid II offers this functionality.

What is the difference between Holter ECG and regular ECG?

A Holter test is ordered when a standard ECG test is not sufficient. Indications for its implementation include primarily diagnostics of arrhythmias, especially paroxysmal ones. Such arrhythmias occur at different times of the day, sometimes only in sleep, sometimes during increased physical activity of the patient. A short scan may not register a serious episode at all.
Another indication is the assessment of arrhythmia intensity and treatment effectiveness. In the case of premature beats, both ventricular and supraventricular, their number during the day is clinically relevant.
Similarly, in the case of atrial fibrillation, the total fibrillation time is assessed, among others.
A Holter test is also prescribed for patients who have had a heart attack or ischemic stroke.
Myocardial necrosis may be the cause of life-threatening ventricular arrhythmias, sometimes
imperceptible by the patient. Therefore, long-term ECG is indicated in patients after a heart attack, even if they do not report arrhythmia.
In turn, ischemic stroke is often a consequence of thrombus caused by atrial fibrillation. Flickering episodes, especially at night, may not be felt by the patient. If suspicion of paroxysmal atrial fibrillation is currently recommended, a test longer than 24 hours is recommended because episodes
of fibrillation do not have to occur every day. Using the Holter functionality of PulseGrid II, you can
perform tests of any length - from 24h to even 30 days.

What is remote holter analysis?

Holter examination, like any ECG examination, must be assessed by a physician. It is quite a tedious
process due to the length of the record. Therefore, an indispensable element of the Holter system is cardiology support software. The most important task of the software is to find and pre-assess places on the ECG, so that the doctor can only assess pathologies and make any corrections.
Then the software calculates various statistical parameters - counts incorrect beats, calculates averages, creates charts. The doctor decides which elements of the analysis will be included in the final report.
Currently, due to the shortage of doctors, remote analysis is beginning to play an important role. Due to universal access to the Internet, a doctor does not have to come to the clinic where the examination was performed. He can describe them remotely, for example from home. Thanks to this, one cardiologist can describe tests in many small outpatient clinics. The patient gains double – he waits for the description shorter and can use the services of the clinic located near the house.